ZLCS Insider Trading Activity and SEC Form 4 Filings
ZLCS insider trading summary
No open-market insider purchases or sales of Zalicus Inc. (ZLCS) have been reported on SEC Form 4 in the past 12 months.
Latest ZLCS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 15, 2013 | Mark Corrigan | President & CEO | Sell | $87K (112,850 @ $0.77) |
| Jan 27, 2012 | Jason Cole | SVP & General Counsel | Sell | $3K (2,420 @ $1.09) |
| Jan 17, 2012 | Mark Corrigan | President & CEO | Sell | $78K (68,105 @ $1.14) |
| Oct 27, 2011 | Nicholas Galakatos | 10% Owner | Sell | $761K (738,807 @ $1.03) |
| Oct 27, 2011 | Luke Evnin | 10% Owner | Sell | $761K (738,807 @ $1.03) |
| Oct 27, 2011 | MPM BIOVENTURES III GMBH & CO. Beteiligungs KG | 10% Owner | Sell | $761K (738,807 @ $1.03) |
| Oct 27, 2011 | Mpm Bioventures III LLC | 10% Owner | Sell | $761K (738,807 @ $1.03) |
| Oct 27, 2011 | Mpm Bioventures III L.P. | 10% Owner | Sell | $761K (738,807 @ $1.03) |
| Oct 27, 2011 | Mpm Bioventures III Parallel Fund, L.P. | 10% Owner | Sell | $761K (738,807 @ $1.03) |
| Oct 27, 2011 | Ansbert Gadicke | 10% Owner | Sell | $761K (738,807 @ $1.03) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.